Skip to content
⌘ K
Log inSign up

By Intermission· 972 words

ResearchEvidenceQuestion

What are the best applications of AI in the physical world for Biotechnology and Medical Instruments?

Evidence(8)

  1. Siemens Healthineers reports FY2025 imaging scale

    [13]

    Siemens Healthineers reported FY2025 revenue of €23.375 billion, including €13.182 billion from Imaging. The report treats the installed base and related service and spare-parts activity as an important foundation for monetizing AI-enabled imaging workflows.

    1

    The report uses Siemens Healthineers’ FY2025 scale to show that imaging already has a substantial equipment, service and installed-base economics. This supports imaging as the clearest near-term commercialization case, while cautioning that AI may reinforce an existing franchise rather than create a standalone software business.

  2. GE HealthCare discloses AI-enabled device authorizations

    [14]

    GE HealthCare’s 2025 annual-report evidence cited 115 AI-enabled FDA authorizations and ultrasound guidance that provides real-time acquisition instructions. The report uses this as evidence of imaging commercialization and workflow potential, not as proof of realized financial returns.

  3. Intuitive Surgical reports established FY2025 platform economics

    [15]

    Intuitive Surgical reported approximately $10.1 billion of 2025 revenue, up 21%, alongside recurring instruments-and-accessories sales. The report uses these established procedural economics—not separately demonstrated AI revenue—as the basis for evaluating potential surgical-AI benefits.

  4. Labcorp and Roche collaborate on digital pathology

    [16]

    Labcorp announced a collaboration with Roche to implement FDA-cleared VENTANA DP 600 and DP 200 slide scanners. The investment supports diagnosis using digital images and creates a foundation for future AI integration, while storage, workflow integration, validation and pathologist acceptance remain constraints.

  5. Intuitive Surgical acquires an integrated robotics and AI developer

    [10]

    In November 2025, Intuitive Surgical acquired a company developing integrated robotics and artificial-intelligence solutions intended to improve surgical accuracy and efficiency. The report cautions that robotics is not inherently AI and that the AI-specific commercial contribution remains unestablished.

  6. Thermo Fisher and NVIDIA announce strategic laboratory-AI collaboration

    [17]

    Thermo Fisher Scientific announced a strategic collaboration with NVIDIA to apply AI to scientific instruments, laboratory infrastructure and data, with the goal of increasing laboratory automation, accuracy and speed. The report describes the opportunity as a path toward connected and autonomous laboratories, while noting that broad deployment is not established.

  7. Danaher reports full-year 2025 results

    [18][2]

    Danaher reported 2025 revenue of $24.6 billion, operating cash flow of $6.4 billion and non-GAAP free cash flow of $5.3 billion. The report uses these figures to show franchise scale and financial capacity, not to claim that AI has already generated corresponding returns.

  8. Danaher invests in bioprocessing capacity, including digital and AI capabilities

    [2]

    Danaher stated that it had deployed more than $2 billion over several years to expand bioprocessing capacity, including digital and AI capabilities. The report clarifies that this was not $2 billion spent exclusively on AI; it is evidence of broader bioprocessing investment and longer-term potential.

Sources

  1. 1.
  2. 2.
  3. 3.
  4. 4.
  5. 5.
  6. 6.
  7. 7.
  8. 8.
  9. 9.
  10. 10.
  11. 11.
  12. 12.
  13. 13.
  14. 14.
  15. 15.
  16. 16.
  17. 17.
  18. 18.

Comments

LatestPopular
Write a comment
Loading comments…

Request a Thesis

Tell us what you’d like Roadstar to investigate.

New question

What would you like to know?

Context guides the research and is not shown on the finished page.